Gastric/Gastroesophageal Junction Cancer
Also known as: Gastric and Gastroesophageal Junction Cancer / Gastric Cancer, Gastroesophageal Junction Cancer / Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) / Gastric or Gastroesophageal Junction Cancer
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB18411 | Anbenitamab | 1 | Active Not Recruiting | 1 |
DB15036 | Sitravatinib | 1 / 2 | Completed | 1 |
DB14922 | Tislelizumab | 1 / 2 | Completed | 1 |
DB18411 | Anbenitamab | 2 | Completed | 1 |
DB01101 | Capecitabine | 2 | Recruiting | 1 |
DB00526 | Oxaliplatin | 2 | Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Recruiting | 1 |
DB05578 | Ramucirumab | 2 | Recruiting | 1 |
DB14765 | Rivoceranib | 2 | Recruiting | 1 |
DB17451 | Serplulimab | 2 | Recruiting | 2 |
DB17517 | Retlirafusp alfa | 3 | Active Not Recruiting | 1 |
DB00072 | Trastuzumab | Not Available | Completed | 1 |